Cerebrospinal fluid biomarkers of axonal and synaptic degeneration in a population-based sample

被引:3
作者
Radestig, Maya Arvidsson [1 ,2 ]
Skoog, Ingmar [1 ,2 ,3 ]
Skillback, Tobias [1 ,2 ]
Zetterberg, Henrik [2 ,4 ,5 ,6 ,7 ]
Kern, Jurgen [1 ]
Zettergren, Anna [1 ,2 ]
Andreasson, Ulf [2 ,4 ]
Wetterberg, Hanna [1 ,2 ]
Kern, Silke [1 ,2 ,3 ]
Blennow, Kaj [2 ,4 ]
机构
[1] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Neuropsychiat,Epidemiol Unit, Gothenburg, Sweden
[2] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Gothenburg, Sweden
[3] Sahlgrens Univ Hosp, Dept Psychiat Cognit & Old Age Psychiat, Gothenburg, Sweden
[4] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Clin Neurochem Lab, Molndal, Sweden
[5] UCL Inst Neurol, Dept Neurodegenerat Dis, Queen Sq, London WC1N 3BG, England
[6] UK Dementia Res Inst UCL, London WC1N 3BG, England
[7] Hong Kong Ctr Neurodegenerat Dis, Hong Kong, Peoples R China
基金
美国国家卫生研究院; 欧盟地平线“2020”; 欧洲研究理事会;
关键词
Alzheimer's disease; Cerebrospinal fluid; CSF; biomarkers; Neurolfilament light; NfL; Neurogranin; ALZHEIMERS-DISEASE; NEUROFILAMENT LIGHT; TAU; NEUROGRANIN; DEMENTIA; PROTEIN; BRAIN; A-BETA(1-42); ASSOCIATION; MARKER;
D O I
10.1186/s13195-023-01193-x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BackgroundNeurofilament light (NfL) and neurogranin (Ng) are promising candidate AD biomarkers, reflecting axonal and synaptic damage, respectively. Since there is a need to understand the synaptic and axonal damage in preclinical Alzheimer's disease (AD), we aimed to determine the cerebrospinal fluid (CSF) levels of NfL and Ng in cognitively unimpaired elderly from the Gothenburg H70 Birth Cohort Studies classified according to the amyloid/tau/neurodegeneration (A/T/N) system.MethodsThe sample consisted of 258 cognitively unimpaired older adults (age 70, 129 women and 129 men) from the Gothenburg Birth Cohort Studies. We compared CSF NfL and Ng concentrations in A/T/N groups using Student's T-test and ANCOVA.ResultsCSF NfL concentration was higher in the A-T-N+ group (p=0.001) and the A-T+N+ group (p=0.006) compared with A-T-N-. CSF Ng concentration was higher in the A-T-N+, A-T+N+, A+T-N+, and A+T+N+ groups (p<0.0001) compared with A-T-N-. We found no difference in NfL or Ng concentration in A+ compared with A- (disregarding T- and N- status), whereas those with N+ had higher concentrations of NfL and Ng compared with N- (p<0.0001) (disregarding A- and T- status).ConclusionsCSF NfL and Ng concentrations are increased in cognitively normal older adults with biomarker evidence of tau pathology and neurodegeneration.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Improved Differential Diagnosis of Alzheimer's Disease by Integrating ELISA and Mass Spectrometry-Based Cerebrospinal Fluid Biomarkers
    Khoonsari, Payam Emami
    Shevchenko, Ganna
    Herman, Stephanie
    Remnestal, Julia
    Giedraitis, Vilmantas
    Brundin, RoseMarie
    Gunnarsson, Malin Degerman
    Kilander, Lena
    Zetterberge, Henrik
    Nilsson, Peter
    Lannfelt, Lars
    Ingelsson, Martin
    Kultima, Kim
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 67 (02) : 639 - 651
  • [32] Concordance and Diagnostic Accuracy of [11C]PIB PET and Cerebrospinal Fluid Biomarkers in a Sample of Patients with Mild Cognitive Impairment and Alzheimer's Disease
    Leuzy, Antoine
    Carter, Stephen F.
    Chiotis, Konstantinos
    Almkvist, Ove
    Wall, Anders
    Nordberg, Agneta
    JOURNAL OF ALZHEIMERS DISEASE, 2015, 45 (04) : 1077 - 1088
  • [33] Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease
    Zhang, Hua
    Therriault, Joseph
    Kang, Min Su
    Ng, Kok Pin
    Pascoal, Tharick A.
    Rosa-Neto, Pedro
    Gauthier, Serge
    ALZHEIMERS RESEARCH & THERAPY, 2018, 10
  • [34] Comparative Analysis of Alzheimer's Disease Cerebrospinal Fluid Biomarkers Measurement by Multiplex SOMAscan Platform and Immunoassay-Based Approach
    Timsina, Jigyasha
    Gomez-Fonseca, Duber
    Wang, Lihua
    Do, Anh
    Western, Dan
    Alvarez, Ignacio
    Aguilar, Miquel
    Pastor, Pau
    Henson, Rachel L.
    Herries, Elizabeth
    Xiong, Chengjie
    Schindler, Suzanne E.
    Fagan, Anne M.
    Bateman, Randall J.
    Farlow, Martin
    Morris, John C.
    Perrin, Richard
    Moulder, Krista
    Hassenstab, Jason
    Chhatwal, Jasmeer
    Mori, Hiroshi
    Sung, Yun Ju
    Cruchaga, Carlos
    JOURNAL OF ALZHEIMERS DISEASE, 2022, 89 (01) : 193 - 207
  • [35] Tau Rather than TDP-43 Proteins are Potential Cerebrospinal Fluid Biomarkers for Frontotemporal Lobar Degeneration Subtypes: A Pilot Study
    Kuiperij, H. Bea
    Versleijen, Alexandra A. M.
    Beenes, Marijke
    Verwey, Nicolaas A.
    Benussi, Luisa
    Paterlini, Anna
    Binetti, Giuliano
    Teunissen, Charlotte E.
    Raaphorst, Joost
    Schelhaas, Helenius J.
    Kusters, Benno
    Pijnenburg, Yolande A. L.
    Ghidoni, Roberta
    Verbeek, Marcel M.
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 55 (02) : 585 - 595
  • [36] Cerebrospinal fluid-based kinetic biomarkers of axonal transport in monitoring neurodegeneration
    Fanara, Patrizia
    Wong, Po-Yin A.
    Husted, Kristofor H.
    Liu, Shanshan
    Liu, Victoria M.
    Kohlstaedt, Lori A.
    Riiff, Timothy
    Protasio, Joan C.
    Boban, Drina
    Killion, Salena
    Killian, Maudi
    Epling, Lorrie
    Sinclair, Elisabeth
    Peterson, Julia
    Price, Richard W.
    Cabin, Deborah E.
    Nussbaum, Robert L.
    Bruehmann, Joerg
    Brandt, Roland
    Christine, Chadwick W.
    Aminoff, Michael J.
    Hellerstein, Marc K.
    JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (09) : 3159 - 3169
  • [37] Cerebrospinal Fluid Biomarkers of Synaptic Dysfunction Are Altered in Parkinson's Disease and Related Disorders
    Nilsson, Johanna
    Constantinescu, Julius
    Nellgard, Bengt
    Jakobsson, Protik
    Brum, Wagner S.
    Gobom, Johan
    Forsgren, Lars
    Dalla, Keti
    Constantinescu, Radu
    Zetterberg, Henrik
    Hansson, Oskar
    Blennow, Kaj
    Backstrom, David
    Brinkmalm, Ann
    MOVEMENT DISORDERS, 2023, 38 (02) : 267 - 277
  • [38] Cerebrospinal fluid biomarkers for predicting development of multiple sclerosis in acute optic neuritis: a population-based prospective cohort study
    M. N. Olesen
    K. Soelberg
    B. Debrabant
    A. C. Nilsson
    S. T. Lillevang
    J. Grauslund
    I. Brandslund
    J. S. Madsen
    F. Paul
    T. J. Smith
    S. Jarius
    N. Asgari
    Journal of Neuroinflammation, 16
  • [39] Cerebrospinal fluid biomarkers for predicting development of multiple sclerosis in acute optic neuritis: a population-based prospective cohort study
    Olesen, M. N.
    Soelberg, K.
    Debrabant, B.
    Nilsson, A. C.
    Lillevang, S. T.
    Grauslund, J.
    Brandslund, I.
    Madsen, J. S.
    Paul, F.
    Smith, T. J.
    Jarius, S.
    Asgari, N.
    JOURNAL OF NEUROINFLAMMATION, 2019, 16 (1)
  • [40] Cerebrospinal fluid biomarkers of neurofibrillary tangles and synaptic dysfunction are associated with longitudinal decline in white matter connectivity: A multi-resolution graph analysis
    Kim, Won Hwa
    Racine, Annie M.
    Adluru, Nagesh
    Hwang, Seong Jae
    Blennow, Kaj
    Zetterberg, Henrik
    Carlsson, Cynthia M.
    Asthana, Sanjay
    Koscik, Rebecca L.
    Johnson, Sterling C.
    Bendlin, Barbara B.
    Singh, Vikas
    NEUROIMAGE-CLINICAL, 2019, 21